- Timely Epinephrine for Pediatric In-Hospital Cardiac Arrest
Andersen LW, Berg, KM, Saindon BZ, et al; American Heart Associaton Get With the Guidelines—Resuscitation Investigators. Time to epinephrine and survival after pediatric in-hospital cardiac arrest. JAMA. 2015;314(8):802-810. Tasker RC, Randolph AG. Pediatric pulseless arrest with “nonshockable” rhythm: does faster time to epinephrine improve outsome? JAMA. 2015;314(8):776-777. - ED Care Pathway Hastens Febrile Neutropenia Therapy
Keng MK, Thallner EA, Elson P, et al. Reducing time to antibiotic administration for febrile neutropenia in the emergency department [published online ahead of print July 28, 2015]. J Oncol Pract. - ESC: Aldosterone Blockade Fails to Fly for Early MI in ALBATROSS
Aldosterone Lethal Effects Blocked in AMI Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-up: THE ALBATROSS TRIAL. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2015 September 14. Available from: https://clinicaltrials.gov/ct2/show/NCT01059136. Pitt B, Remme W, Zannad F, et al; Eplerenon Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348(14)1309-1321. - Inpatient Mortality Down for High-Volume Conditions
Statistical Brief #194. Trends in Observed Adult Inpatient Mortality for High-Volume Conditions, 2002-2012. Healthcare Cost and Utilization Project (HCUP). July 2015. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/reports/statbriefs/sb194-Inpatient-Mortality-High-Volume-Conditions.jsp. Accessed August 20, 2015.
